Clinical Trial Update: Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating the combination of duvelisib with nivolumab in patients with advanced unresectable melanoma has been terminated, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• COPIKTRA (duvelisib)
• OPDIVO (nivolumab)

Snippet

Sponsor: John Kirkwood | Conditions: Unresectable Melanoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-12-17